These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 35040137)

  • 1. How safe and effective is the use of bisphosphonates in the treatment of osteoporosis in children with cerebral palsy? A Cochrane Review summary with commentary.
    Arman S
    Dev Med Child Neurol; 2022 Mar; 64(3):286-288. PubMed ID: 35040137
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of bisphosphonates to treat osteoporosis in children with cerebral palsy: a meta-analysis.
    Kim MJ; Kim SN; Lee IS; Chung S; Lee J; Yang Y; Lee I; Koh SE
    J Pediatr Endocrinol Metab; 2015 Nov; 28(11-12):1343-50. PubMed ID: 26214607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclic administration of pamidronate to treat osteoporosis in children with cerebral palsy or a neuromuscular disorder: a clinical study.
    Allington N; Vivegnis D; Gerard P
    Acta Orthop Belg; 2005 Feb; 71(1):91-7. PubMed ID: 15792214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consensus guidelines on the use of bisphosphonate therapy in children and adolescents.
    Simm PJ; Biggin A; Zacharin MR; Rodda CP; Tham E; Siafarikas A; Jefferies C; Hofman PL; Jensen DE; Woodhead H; Brown J; Wheeler BJ; Brookes D; Lafferty A; Munns CF;
    J Paediatr Child Health; 2018 Mar; 54(3):223-233. PubMed ID: 29504223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are bisphosphonates effective in treating osteoporosis in children and adults with cystic fibrosis?-A Cochrane review summary with commentary.
    Akpinar FM
    Int J Rheum Dis; 2024 Mar; 27(3):e15074. PubMed ID: 38450928
    [No Abstract]   [Full Text] [Related]  

  • 6. Bisphosphonate treatment for children with disabling conditions.
    Boyce AM; Tosi LL; Paul SM
    PM R; 2014 May; 6(5):427-36. PubMed ID: 24368091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secondary osteoporosis in long-term bedridden patients with cerebral palsy.
    Iwasaki T; Takei K; Nakamura S; Hosoda N; Yokota Y; Ishii M
    Pediatr Int; 2008 Jun; 50(3):269-75. PubMed ID: 18533934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bisphosphonate treatment of pediatric bone disease.
    Speiser PW; Clarson CL; Eugster EA; Kemp SF; Radovick S; Rogol AD; Wilson TA;
    Pediatr Endocrinol Rev; 2005 Dec; 3(2):87-96. PubMed ID: 16361982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone density in cerebral palsy.
    Houlihan CM; Stevenson RD
    Phys Med Rehabil Clin N Am; 2009 Aug; 20(3):493-508. PubMed ID: 19643349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcomes of children and adolescents who had cerebral palsy with secondary osteoporosis.
    Iwasaki T; Nonoda Y; Ishii M
    Curr Med Res Opin; 2012 May; 28(5):737-47. PubMed ID: 22126423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Informing evidence-based clinical practice guidelines for children with cerebral palsy at risk of osteoporosis: an update.
    Ozel S; Switzer L; Macintosh A; Fehlings D
    Dev Med Child Neurol; 2016 Sep; 58(9):918-23. PubMed ID: 27435427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Osteoporosis in children with cerebral palsy].
    Linglart A; Marchand I; Djavidi A; Senez C; Benigni I; Rothenbuhler A; Forin V
    Arch Pediatr; 2009 Jun; 16(6):614-5. PubMed ID: 19541105
    [No Abstract]   [Full Text] [Related]  

  • 13. Osteopenia in cerebral palsy.
    Shaw NJ; White CP; Fraser WD; Rosenbloom L
    Arch Dis Child; 1994 Sep; 71(3):235-8. PubMed ID: 7979497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of corrected QT interval prolongation after pamidronate infusion in children.
    Rothenbuhler A; Marchand I; Bougnères P; Linglart A
    J Clin Endocrinol Metab; 2010 Aug; 95(8):3768-70. PubMed ID: 20501688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone health in cerebral palsy and introduction of a novel therapy.
    Scheinberg MA; Golmia RP; Sallum AM; Pippa MG; Cortada AP; Silva TG
    Einstein (Sao Paulo); 2015; 13(4):555-9. PubMed ID: 26761553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bisphosphonates for osteoporosis in primary biliary cirrhosis.
    Rudic JS; Giljaca V; Krstic MN; Bjelakovic G; Gluud C
    Cochrane Database Syst Rev; 2011 Dec; (12):CD009144. PubMed ID: 22161446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bisphosphonate therapy in children with secondary osteoporosis.
    Papapoulos SE
    Horm Res Paediatr; 2011; 76 Suppl 1():24-7. PubMed ID: 21778744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bisphosphonates in the treatment of HIV-related osteoporosis.
    Vescini F; Grimaldi F
    Endocrine; 2015 Mar; 48(2):358-9. PubMed ID: 25424437
    [No Abstract]   [Full Text] [Related]  

  • 19. Fracture after bisphosphonate treatment in children with cerebral palsy: the role of stress risers.
    Harcke HT; Stevenson KL; Kecskemethy HH; Bachrach SJ; Grissom LE
    Pediatr Radiol; 2012 Jan; 42(1):76-81. PubMed ID: 21877116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bisphosphonates to treat osteopenia in children with quadriplegic cerebral palsy: a randomized, placebo-controlled clinical trial.
    Henderson RC; Lark RK; Kecskemethy HH; Miller F; Harcke HT; Bachrach SJ
    J Pediatr; 2002 Nov; 141(5):644-51. PubMed ID: 12410192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.